Skip to main content

Table 5 Survival analysis was performed by univariate and multivariate Cox regression analysis

From: CILP2 overexpression correlates with tumor progression and poor prognosis in patients with colorectal cancer in The Cancer Genome Atlas (TCGA) study

Variables

Univariate analysis

Multivariate analysis

P value

HR

95% CI

P value

HR

95% CI

CILP2 expression (high vs. low)

0.003

1.713

1.194–2.457

0.034

1.547

1.033–2.317

Gender (male vs. female)

0.941

0.987

0.694–1.404

0.132

1.351

0.913–1.999

Age (> 68 vs. ≤ 68)

< 0.0001

1.923

1.337–2.767

< 0.0001

2.626

1.743–3.957

T stage (T3/4 vs. T1/2)

0.005

2.457

1.320–4.572

0.143

1.817

0.816–4.044

N stage (N1/2/3 vs. N0)

< 0.0001

2.734

1.897–3.942

0.264

0.589

0.232–1.491

M stage (M1 vs. M0)

< 0.0001

4.126

2.776–6.133

< 0.0001

2.854

1.769–4.604

Clinical stage (III/IV vs. I/II)

< 0.0001

3.

2.046–4.401

0.017

3.408

1.244–9.337

  1. P value < 0.05 was considered statistically significant (in bold). T tumor, N regional lymph node, M metastasis, HR hazard ratio, CI confidence interval